成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >ASO Oligo-Z
ASO Oligo-Z
  • ASO Oligo-Z

ASO Oligo-Z NEW

Price Get Latest Price
Package 20mg
Min. Order: 10mg
Supply Ability: 1kg
Update Time: 2025-01-03

Product Details

Product Name: ASO Oligo-Z Min. Order: 10mg
Purity: 95 Supply Ability: 1kg
Release date: 2025/01/03

Antisense oligonucleotides (ASOs) are oligonucleotides that induce gene silencing.Typically,ASOs are 15-22 nucleotides in length and are designed to bindcomplementary RNA targets, ultimatelyfacilitating their degradation via the RNase Hpathway. Our well-established expertise in oligo synthesis makes us a trusted vendor for ASOs.



Company Profile Introduction

Allbiosyn is a one-stop raw materials and service platform for nucleic acid therapeutics. Our primary focus lies in delivering cutting-edge solutions, with a product portfolio spanning from dNTP, NTP, modified NTP, mRNA cap analogues, phosphoramidites, modified nucleosides and nucleotides, chemluminescent reagents, fluorescent dyes, gene sequencing reagents, bilogical enzymes, recombinant proteins CRO services, etc. Allbiosyn brings together top chemical experts from Stanford University, Peking University, Tsinghua University, University of Science and Technology of China, Zhejiang University etc. Our mission is to be an excellent supplier of nucleoside & nucleic acid raw materials for nucleic acid drugs, DNA/RNA synthesis and mRNA vaccines.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/20MG
VIP3Y
Changsha Staherb Natural Ingredients Co., Ltd.
2022-09-05
$2380.00/250μg
VIP5Y
TargetMol Chemicals Inc.
2024-10-23
$0.00/1mg
VIP3Y
TargetMol Chemicals Inc.
2024-10-23
  • Since: 2023-11-02
  • Address: Building 1,883-885 Pinggang Road, Lingang District,Pilot Free Trade Zone,Shanghai,china
INQUIRY